- Home
- Search Results
- Page 1 of 1
Search for: All records
-
Total Resources2
- Resource Type
-
0001000001000000
- More
- Availability
-
20
- Author / Contributor
- Filter by Author / Creator
-
-
Conley, Thomas (2)
-
Aljitawi, Omar (1)
-
Becker, Michael W. (1)
-
Calvi, Laura M. (1)
-
Dokholyan, Nikolay V. (1)
-
Gerber, Scott A. (1)
-
Goto, Takuro (1)
-
Hansen, Jeanne N. (1)
-
Hong, Jennifer (1)
-
Jurutka, Peter W. (1)
-
Kalita, Jugal (1)
-
Kawano, Hiroki (1)
-
Kawano, Yuko (1)
-
Khazan, Negar (1)
-
Khera, Manoj K. (1)
-
Kim, Kyu Kwang (1)
-
Liesveld, Jane (1)
-
Linehan, David C. (1)
-
Miller, John P. (1)
-
Miyamoto, Hiroshi (1)
-
- Filter by Editor
-
-
& Spizer, S. M. (0)
-
& . Spizer, S. (0)
-
& Ahn, J. (0)
-
& Bateiha, S. (0)
-
& Bosch, N. (0)
-
& Brennan K. (0)
-
& Brennan, K. (0)
-
& Chen, B. (0)
-
& Chen, Bodong (0)
-
& Drown, S. (0)
-
& Ferretti, F. (0)
-
& Higgins, A. (0)
-
& J. Peters (0)
-
& Kali, Y. (0)
-
& Ruiz-Arias, P.M. (0)
-
& S. Spitzer (0)
-
& Sahin. I. (0)
-
& Spitzer, S. (0)
-
& Spitzer, S.M. (0)
-
(submitted - in Review for IEEE ICASSP-2024) (0)
-
-
Have feedback or suggestions for a way to improve these results?
!
Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher.
Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?
Some links on this page may take you to non-federal websites. Their policies may differ from this site.
-
Small-molecule inhibitors of PD-L1 are postulated to control immune evasion in tumors similar to antibodies that target the PD-L1/PD-1 immune checkpoint axis. However, the identity of targetable PD-L1 inducers is required to develop small-molecule PD-L1 inhibitors. In this study, using chromatin immunoprecipitation (ChIP) assay and siRNA, we demonstrate that vitamin D/VDR regulates PD-L1 expression in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) cells. We have examined whether a VDR antagonist, MeTC7, can inhibit PD-L1. To ensure that MeTC7 inhibits VDR/PD-L1 without off-target effects, we examined competitive inhibition of VDR by MeTC7, utilizing ligand-dependent dimerization of VDR-RXR, RXR-RXR, and VDR-coactivators in a mammalian 2-hybrid (M2H) assay. MeTC7 inhibits VDR selectively, suppresses PD-L1 expression sparing PD-L2, and inhibits the cell viability, clonogenicity, and xenograft growth of AML cells. MeTC7 blocks AML/mesenchymal stem cells (MSCs) adhesion and increases the efferocytotic efficiency of THP-1 AML cells. Additionally, utilizing a syngeneic colorectal cancer model in which VDR/PD-L1 co-upregulation occurs in vivo under radiation therapy (RT), MeTC7 inhibits PD-L1 and enhances intra-tumoral CD8+T cells expressing lymphoid activation antigen-CD69. Taken together, MeTC7 is a promising small-molecule inhibitor of PD-L1 with clinical potential.more » « less
-
Conley, Thomas; St. Clair, Jack; Kalita, Jugal (, International Conference on Natural Language Processing)Although people have the ability to en- gage in vapid dialogue without effort, this may not be a uniquely human trait. Since the 1960’s researchers have been trying to create agents that can generate artificial conversation. These programs are com- monly known as chatbots. With increasing use of neural networks for dialog genera- tion, some conclude that this goal has been achieved. This research joins the quest by creating a dialog generating Recurrent Neural Network (RNN) and by enhancing the ability of this network with auxiliary loss functions and a beam search. Our cus- tom loss functions achieve better cohesion and coherence by including calculations of Maximum Mutual Information (MMI) and entropy. We demonstrate the effectiveness of this system by using a set of custom evaluation metrics inspired by an abun- dance of previous research and based on tried-and-true principles of Natural Lan- guage Processing.more » « less
An official website of the United States government

Full Text Available